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Abstract
The aim of this study is to disclose the potential bioactive components of Cuscuta palaes-
tina, a native parasitic natural plant of flora palaestina and to open direction towards new
prospective application. GC-MS analysis identified 18 components in the methanolic extract
of C. palaestina for the first time. The most appealing among them are Sesamin and two
other phytosterols (Campesterol and Stigmasterol), all of which are documented in the sci-
entific literature for their anticancer activity. Quantitation of Sesamin extracted from C. pal-
aestina by HPLC-PDA with the use of three organic solvents showed that the Sesamin
content in the methanolic extract was the highest. Following the disclosure of Sesamin pres-
ence in C. palaestina, we raised the question of whether it is produced naturally in C. palaes-
tina or acquired from the host plant. The quantitation of Sesamin in C. palaestina was
performed while being with five different host plants, and was compared with the amount of
Sesamin in C. palaestina grown alone. The findings reveal that Sesamin is an endogenous
secondary metabolite in C. palaestina. Thus, further studies are required to prove if C. pal-
aestina can be used as an alternative source of anticancer phytochemicals, mainly Sesa-
min, and if proteins in the Sesamin production pathway could be valid biological targets for
the development of novel and selective pesticides for control/ eradication of C. palaestina
and maybe some other Cuscuta species. As well, the findings from this study raise a big
question of whether inferring Sesamin production in C. palaestina could reduce its attack
ability to host plants.
Introduction
Recent years have witnessed a renewed interest in plants as an alternative avenue to the discov-
ery of new pharmaceuticals. This interest is driven by both academia and the pharmaceutical
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industry and has led to the espousal of crude extracts of plants for self-medication by the pub-
lic. Plants used in traditional medicine, therefore, have an increasingly important role to play
in the maintenance of health worldwide and play an important role in the introduction of new
treatments. The World Health Organization (WHO) estimates that up to eighty percent of the
world’s population relies on traditional medicine for some aspect of primary health care. [1]
Herbal medicines have been universally accepted and have had a great impact on the world of
health and international trade. More than 60 percent of the anticancer chemotherapeutic
drugs in current use have been derived in one way or another from natural sources, including
plants. We can identify potential bioactive compounds via a bio-guided fractionation process
[2, 3] or with in silico techniques, [4–10] followed by in vitro/in vivo experiments. The esti-
mated number of plant species on earth ranges between 500,000 and 1,250,000, and less than
ten percent of these have been studied chemically and pharmacologically for their potential
medicinal value. [11]
C. palaestina, which belongs to the family Convolvulaceae, is an extensive climber parasite.
It is more often called dodder in English and Halook or Hamool Falastini in Arabic. The
mature plants have no connection to the ground. The plant has no chlorophyll and cannot
make its own nutrients by photosynthesis. The stem consists of thread-like filaments that grow
and attach themselves to nearby host plants. Cuscuta is a genus of about 100–170 species. [12]
There are no data in the literature concerning the analysis of anti-proliferative and anticancer
activity in these species nor the chemical composition of their constituents. As part of our
efforts to find potential sources of agents that inhibit cancer development, we have investigated
the anticancer effects of C. palaestina crude extract on the colon carcinoma cell line. According
to an intensive literature survey, no GC-MS method has yet been reported for the determina-
tion of the phytochemicals present in C. palaestina. The main constituents of the methanol
and hexane extracts from this plant were explored and investigated by GC-MS in the electron
impact mode and are reported in this paper for the first time. Moreover, an analytical method
was designed to quantify the Sesamin amount present in the plant by using HPLC-PDA. The
results show that C. palaestina provides a reliable and enriched alternative source of Sesamin,
which is commonly isolated from sesame seeds.
Fig 1. Typical analytical HPLC-PDA chromatogram of standard Sesamin at concentration of 250 ppm; the UV-Vis
spectrum maxima is at a λ of 235.5 and 286.4 nm.
https://doi.org/10.1371/journal.pone.0195707.g001
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Fig 2. GC-MS analysis of the methanolic extract of C. palaestina.
https://doi.org/10.1371/journal.pone.0195707.g002
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Material and methods
Plant collection and extract preparation
Samples of entire C. palaestina plants, comprising the stems and flowers, as well as their host
plants, were collected from Kabul fields (near Acre). There is no specific permissions were
required for the used locations/activities and the field studies did not involve endangered or
protected species. The plant was washed with distilled water, and dried in the shade. Quantities
of fifty milliliters of water and five different organic solvents (hexane, methanol, ethanol, ethyl
acetate and chloroform) were added to the dried ground plant material (5 g) in a beaker, and
the samples were sonicated for 120 min at 45˚C and then left for 4 h to complete extraction.
Samples of 25 milliliters from all the extracts were concentrated with a rotary vacuum evapora-
tor under reduced pressure to determine yields and concentrations, and the rest of the extract
was used for GC-MS studies and for quantification by HPLC.
Fig 3. GC-MS analysis of the hexane extract of C. palaestina.
https://doi.org/10.1371/journal.pone.0195707.g003
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GC-MS analysis condition
Components of C. palaestina from the methanol and hexane extracts were run and identified
using a GC-MS system (Agilent Technologies 7890A) coupled with a mass spectrometer (Agi-
lent Technologies 5975C, inert MSD with a triple-axis detector). The GC was operated on an
Agilent J&W GC column HP-5 column (30 m x 0.32 mm, id. with a 0.25-μm film thickness).
The carrier gas was helium, at a flow rate of 1.2 mL/min, and the injection volume was 1μL. The
injection port temperature was 300˚C, and the ionization voltage was 70eV. The samples were
injected in split mode with a ratio of 10:1. Mass spectra were recorded with a scan every second
over a range of 45–800 (m/z). The oven temperature program was started at 50˚C and set for 5
min, ramped up to 320˚C with a heating rate of 5˚C/min, and then finally held for an extra 20
min. The injection port temperature was 280˚C, and the MS interface temperature was 300˚C.
The solvent delay time was 7 min, in order to get rid of the gigantic solvent peak. The mass spec-
tra obtained were preliminarily interpreted by comparing them with data in the Mass Spectral
Library of the National Institute of Standards and Technology (NIST, Gaithersburg, USA).
Table 1. Components of C. palaestina methanolic extract verified by GC-MS. Three phytochemicals–namely Sesamin, campesterol, and stigmasterol–are bolded and
could be the source of the methanolic extract’s anticancer activity.
No. Compound name RT (min) Peak Area %
1 Propanoic acid 11.631 2.619
2 2-Methylbenzaldehyde 17.653 5.376
3 1-Formylpyrrolidine 19.460 1.754
4 2-Methoxy-4-vinylphenol 20.298 4.930
5 1,6-Anhydro-β-D-glucose 24.872 1.543
6 Hexanoic acid 27.714 1.087
7 Dodecanoic acid isooctyl ester 35.149 20.965
8 Palmitic acid 35.273 10.582
9 (Z,Z)-9,12-Octadecadienoic acid 38.382 1.755
10 Palmitoleic acid 38.503 3.915
11 Oleic acid 38.800 1.860
12 2-Fluoro-3-trifluoromethylbenzoic acid, heptadecyl ester 45.469 6.700
13 2-Fluoro-5-trifluoromethylbenzoic acid, heptadecyl ester 46.236 6.875
14 Sesamin 53.502 4.490
15 ethanone, 2-(3H-imidazo[4,5-b]pyridin-2-ylthio)-1-(4-morpholinyl)- 54.172 3.222
16 Campesterol 54.359 1.449
17 Stigmasterol 54.689 1.007
18 Pregn-5-en-3-ol, 21-bromo-20-methyl-, (3.beta.)- 55.429 4.461
https://doi.org/10.1371/journal.pone.0195707.t001
Table 2. Components of C. palaestinahexane extract as determined by GC-MS. Sesamin is bolded and could be the
source of the hexane extract’s anticancer activity.
No. Compound name RT (min) Peak Area %
1 Trans-3,4-Dimethyl-2-pentene 9.401 8.418
2 Eicosane 44.622 0.654
3 Heneicosane 47.610 1.782
4 Docosane 49.023 0.98
5 8-Hexylpentadecane 50.409 54.656
6 11-Butyl-docosane 51.709 1.735
7 9-Octylheptadecane 52.998 9.326
8 Sesamin 53.505 1.138
9 2-(1-adamantyl)ethyl 2-phenylacetate 55.428 2.112
https://doi.org/10.1371/journal.pone.0195707.t002
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Method for the quantitative analysis of the Sesamin content of C.
palaestina by analytical HPLC-PDA
Chromatographic conditions were used to separate and quantify the Sesamin in C. palaestina.
Crude samples were run on a reversed-phase ODS column by Waters (XBridge, 4.6 ID x 150
Fig 4. Chemical structures of the major components in the methanolic C. palaestina extract.
https://doi.org/10.1371/journal.pone.0195707.g004
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mm, 5 μm), with a guard column of XBridge ODS (20 mm x 4.6mm ID, 5 μm). The mobile
phase consisted of binary solvent mixture of 0.5% acetic acid solution (A) and acetonitrile (B),
in linear gradient mode. The start was a 100% (A) that descended to 70% (A) in 40 min. Then
to 40% (A) in 20 min and finally to 10% (A) in 2 min and stayed there for 6 min and then back
to the initial conditions in 2 min. The HPLC system was equilibrated for 5 min with the initial
acidic water mobile phase (100% A) before the next sample was injected. All of the samples
Fig 5. Chemical structures of the major components in the n-hexane C. palaestina extract. 8-Hexylpentadecane is
the principal component (54.65%).
https://doi.org/10.1371/journal.pone.0195707.g005
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were filtered with a 0.45-μm PTFE filter. The PDA wavelengths ranged from 210–500 nm, the
flow rate was 1 mL/min, the injection volume was 10 μl, and the column temperature was
room temperature. The Sesamin was eluted with a retention time of 54.6 min.
Calibration curve of the standards
Sesamin stock solution was prepared by dissolving 10 mg of Sesamin reference standard (pur-
chased from Sigma Aldrich, Israel) in 40 mL ethanol, which produced a concentration of
250 ppm. The solution was filtered using a 0.45-μm membrane. A five-point calibration curve
was constructed by injecting the diluted solution into the HPLC-PDA, and the value of the
coefficient of determination (R2) was> 0.999. Fig 1 displays a typical HPLC-PDA chromato-
gram of the Sesamin that was used in the current study.
Results and discussion
In examining the phytochemical composition, GC-MS methodology identified 18 components
in the methanol extract of the natural C. palaestina plant for the first time. Understandably,
fewer compounds were identified in the hexane extract. Figs 2 and 3 show the entire ion chro-
matograms of the methanol and hexane extract injections, respectively. Good resolution was
Fig 6. Chemical structure of Sesamin, the phytochemical potentially responsible for anticancer activity in the C.
palaestinahexane extract and the major source of the methanolic extract activity.
https://doi.org/10.1371/journal.pone.0195707.g006
Fig 7. Chemical structures of Campesterol and Stigmasterol, phytochemicals found in the methanolic extract of C.
palaestina.
https://doi.org/10.1371/journal.pone.0195707.g007
Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications
PLOS ONE | https://doi.org/10.1371/journal.pone.0195707 April 10, 2018 8 / 14
Fig 8. Typical analytical HPLC-PDA chromatogram of the Sesamin peak and its relevant UV-Vis spectrum in
extracts of (A) hexane, (B) methanol, (C) ethanol, and (D) chloroform.
https://doi.org/10.1371/journal.pone.0195707.g008
Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications
PLOS ONE | https://doi.org/10.1371/journal.pone.0195707 April 10, 2018 9 / 14
obtained in both chromatograms, since a 79-min analysis scan run was performed, ending
with a high temperature of 320˚C, to facilitate the elution of high molecular weight compounds
out of the capillary GC HP-5 column. Dodecanoic acid isooctyl ester (20.96%), palmitic acid
(10.58%), 2-fluoro-3-trifluoromethylbenzoic acid, heptadecyl ester (6.7%), and 2-fluoro-5-tri-
fluoromethylbenzoic acid, heptadecyl ester (6.88%) are the major compounds in the methanol
extract. The major chemicals in the hexane extract are 8-hexylpentadecane (54.66%), 9-octyl-
heptadecane (9.33%), and trans-3,4-dimethyl-2-pentene (8.42%). The main components,
along with their retention times (RTs) and peak area percentages, are presented in Tables 1
and 2. Figs 4 and 5 show the chemical structures of the major components in the methanolic
and hexane extracts, respectively.
Sesamin (see Fig 6), which exists in the oil of sesame seeds and some other plants, was one
of the major components, as shown in Table 1. It exhibits a variety of biological activities, such
as lipid-lowering [13], antihypertensive [14], antioxidant [15], and anticancer effects. [16] In
regard to its antitumor effects, Sesamin has already been confirmed to be active against several
cancer cell types, including prostate cancer, breast cancer, colon cancer, and human lung can-
cer[17–19]. Other phytochemicals (see Fig 7), which belong to the phytosterols—namely Cam-
pesterol (1.5%) and Stigmasterol (1.0%)—were also noticed, but to a lesser extent, Phytosterols
are structurally similar to cholesterol and are validated in their anti-carcinogenic effects. For
example, Campesterol has been shown to act as biomarker for cancer prevention and is
reported to have potential antiangiogenic action via an inhibition of endothelial cell prolifera-
tion and capillary differentiation. [20] Moreover, Stigmasterol is reported to significantly
inhibit tumor promotion in two-stage carcinogenesis in mice. [21] As well, Dodecanoic acid
isooctyl ester and palmitic acid are the dominant compounds, demonstrating 20.9% and
10.58% decrease in tumor size, respectively.
The hexane extract, on the other hand, was tested for the sake of comparison with the
polar methanol extract. It identified fewer compounds, mainly hydrocarbons, among which
8-hexylpentadecane was the principal compound (54.65%). Sesamin was present, but in lower
concentrations than in the methanol extract. The other two phytosterols (Campesterol and
Stigmasterol) were not found in the hexane extract.
Quantitation of extracted Sesamin using different solvents by HPLC-PDA
Sesamin was extracted from C. palaestina with the use of different solvents under identical
experimental conditions, followed by injection into the HPLC. Retention times and the Sesa-
min stored standard UV-Vis spectrum were used to confirm the identity and specificity of the
extracted Sesamin. Aqueous extract showed a negligible amount of Sesamin. Fig 8 portrays the
chromatographic profile and the corresponding UV-Vis spectra of the Sesamin extracted from
hexane, methanol, ethanol, and chloroform. Although all the chromatograms were recorded at
the maximum wavelength (285 nm) to quantify Sesamin, many other peaks were seen preced-
ing and succeeding Sesamin in the extracts. In the PDA stored UV-Vis spectra, the matching
of the peaks in the A, B, C, and D extracts with the standard Sesamin peak indicates high purity
Table 3. Sesamin concentrations and percentages in different solvents.
Extract RT (min) Area (ppm) Concentration (ppm) % Sesamin
Hexane 54.499 175598 6.1 0.68
Methanol 54.613 625860 21.7 0.22
Ethanol 54.610 308191 10.7 0.43
Chloroform 54.511 116387 9.168 0.53
https://doi.org/10.1371/journal.pone.0195707.t003
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Fig 9. (A) Chromatogram and UV-Vis spectra of extracted C. palaestina that is grown on Malva sylvestris, (B) chromatogram Malva sylvestris, (C) chromatogram and
spectrum of C. palaestina that is grown on Cichorium intybus, (D) chromatogram of Cichorium intybus, (E) chromatogram and spectrum of C. palaestina that is grown
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and specificity, and, therefore, the feasibility of utilizing preparative HPLC for scaling-up pur-
poses in future investigations. Methanol contained the greatest amount of Sesamin (21.7 ppm)
in comparison to the other solvents, and hexane the least (6.1 ppm) (Table 3).
Is Sesamin produced in C. palaestina or acquired from host plants?
To verify whether the Sesamin is endogenous secondary metabolite to C. palaestina or origi-
nates merely from the host plant, different samples from the host plants alone, along with C.
palaestina alone, were extracted, and the Sesamin concentration was calculated (shown in Fig
9). The five host plants were Malva sylvestris, Cichorium intybus, Prosopis farcta, Portulaca oler-
acea, and Corchorus olitorius. Table 4 shows the Sesamin concentrations in methanolic extracts
of C. palaestina that were parasitic to the aforementioned plants. Since the Sesamin peaks were
not seen in the chromatograms of the host plants, it was concluded that Sesamin is endogenous
to C. palaestina.
Conclusion
Sesamin is well documented in the scientific literature as a lipid-lowering agent, an antihyper-
tensive, antioxidant, and anti-cancer drug candidate. It is one of the principal lignan secondary
metabolites that are commonly isolated from sesame seeds. However, the results of the current
study show that natural C. palaestina contains a sufficient amount of Sesamin, about 0.68%,
when methanol as used as the extracting solvent. Following the determination of the Sesamin
content in C. palaestina, we raised the question: Is Sesamin produced in C. palaestina or
acquired from the host plant? The quantitation of the Sesamin content in five host plants and a
comparison to the content in C. palaestina revealed that Sesamin is an endogenous metabolite
in C. palaestina. Further study is required to verify whether C. palaestina could be a valuable
source for the production of Sesamin or other anti-cancer phytochemicals, such as campes-
terol and stigmasterol. As well, we are wondering if genes/ proteins in the Sesamin production
pathway could be valid biological targets for the development of novel and selective pesticides
for C. palaestina and other Cuscuta species. A big question is raised of whether inferring Sesa-
min production in C. palaestina could reduce its attack ability to host plants.
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